To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

A Molecular Epidemiology Study in Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC) of Adeno Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01185314

Acronym

PIONEER

Enrollment

1270

Registered

2010-08-19

Start date

2010-09-30

Completion date

2011-07-31

Last updated

2011-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Small Cell Lung Cancer

Keywords

NSCLC, EGFR mutation

Brief summary

The purpose of this study is to study the changes in protein in lung cells of Asian patients with advanced non small cell lung cancer.

Detailed description

A molecular epidemiology study in Asian patients with advanced NSCLC of adeno histology to assess EGFR mutation status.

Interventions

PROCEDURETesting for mutation status

EGFR mutation test

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SCREENING

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* Histological or cytologically confirmed advanced Non small cell lung cancer of adeno histology NSCLC treatment naive Availability of cancer tissue or cytology sample

Exclusion criteria

* Involvement in the planning and/or conduct of the study Previous enrollment in the present study

Design outcomes

Primary

Measure	Time frame
EGFR mutation status of Asian patients with advanced NSCLC	Samples will be tested after informed consent. Mutation results will be available within 1-3 weeks.

Countries

China, Hong Kong, India, Philippines, Taiwan, Thailand, Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026